In summary, our research confirms that ENO1, as a carcinogen responsible for melanoma, may promote tumor cell proliferation, migration, and invasion through the Wnt/β-catenin pathway, and is a potential target for the treatment of SKCM. Here, ENO1 is linked to neoplasm.